MicroSurgical Technology Inc.

MicroSurgical Technology Inc. specializes in surgical instruments and devices for ophthalmic procedures. Their portfolio includes tools like the Malyugin Ring System, which is used in cataract surgery, and the Trabectome and TrabEx+, designed for glaucoma management. These devices are intended for minimally invasive eye surgeries such as trabeculectomy and phacoemulsification, focusing on precision and reduced invasiveness.

MicroSurgical Technology Inc. is headquartered in the United States. The company’s location in the US influences its regulatory and market focus, particularly in alignment with US and EU standards for ophthalmic surgical devices.

MicroSurgical Technology Inc.’s devices are listed in the eudamed database, which is the European Union’s central registry for medical devices. This inclusion ensures transparency and traceability for devices classified under EU regulations, such as Class IIa and Class IIb.

MicroSurgical Technology Inc.’s devices fall under Class IIa and Class IIb classifications in the EU. Class IIa devices pose a low-to-moderate risk and require conformity assessment procedures like design examination and manufacturing quality assurance, while Class IIb devices carry a higher risk and require additional scrutiny, such as clinical evaluations or performance studies, to ensure safety and performance.